CVS HEALTH CORPORATION Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount
CVS HEALTH CORPORATION (CVS) reported Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount of $65.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount · last filed 2026-02-10
- CVS HEALTH CORPORATION effective income tax rate reconciliation cross border tax effect amount for fiscal 2025 was $65.00M, a 225.00% increase from fiscal 2024.
- CVS HEALTH CORPORATION effective income tax rate reconciliation cross border tax effect amount for fiscal 2024 was $20.00M.
- CVS HEALTH CORPORATION effective income tax rate reconciliation cross border tax effect amount for fiscal 2023 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount 12 month |
|---|---|
| 2025-12-31 | $65.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $20.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |